Skip to main content
SpringerLink
Log in

Risk factors of calcium stone formation in patients with primary Sjögren's syndrome

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Distal renal tubular acidosis (dRTA), which occurs in patients with primary Sjögren's syndrome (SS), is a risk factor for the development of urolithiasis. Twenty-seven patients with SS were evaluated with respect to biochemical risk factors of calcium stone formation. Sixteen had no history of urolithiasis (group 1) whereas 11 had such a history (group 2). The stone composition was known for seven of the patients, and calcium phosphate was the major stone constituent in all of them. dRTA was present in all patients in group 2, and in 7 of the 16 patients in group 1. Hypocitraturia was common inboth groups, and the urinary excretion of citrate did not differ between the two groups. There was a higher urinary excretion of calcium and urate in group 2 and this group also had a higher urine volume. The risk of forming a urine supersaturated with calcium oxalate (CaOx) expressed in terms of AP(CaOx)index(s), which is an approximate estimate of the ion-activity product of CaOx calculated for a 24-h urine volume of 1500 ml, was higher in stone formers. A similarly derived estimate of the ion-activity product of calcium phosphate, AP(CaP)index(s), was calculated for a urine pH of 7. Although AP(CaP)index(s) was not significantly higher in group 2, there was a good correlation between AP(CaP)index(s) and AP(CaOx)index(s). We conclude that the urine composition in patients with SS, dRTA and urolithiasis is similar to that of other stone-forming patients with dRTA, and recurrence preventive therapy can be designed as for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams P, Chalmers TM, Hill LF, Truscot BMcN (1970) Idiopathic hypercalciuria and hyperparathyroidism. BMJ 4:582

    Google Scholar 

  2. Backman U, Danielsson BG, Sohtell M (1976) A short duration renal acidification test. Scand J Urol Nephrol Suppl 35:33

    Google Scholar 

  3. Bingham S, Williams R, Cole T, Price C, Cummings J (1988) Reference values for analytes of 24-h urine collections known to be complete. Ann Clin Biochem 25:610

    Google Scholar 

  4. Brand E, Harris M, Biloon S (1930) Cystinuria: the excretion of a cystine complex which decomposes in the urine with the liberation of free cystine. J Biol Chem 86:315

    Google Scholar 

  5. Buchalew VM (1989) Nephrolithiasis in renal tubular acidosis. J Urol 141:731

    Google Scholar 

  6. Caruana RJ, Buckalew VM (1988) The syndrome of distal (type 1) renal tubular acidosis. Medicine 67:84

    Google Scholar 

  7. Coe FL (1978) Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 13:418

    Google Scholar 

  8. Coe FL, Parks JH (1980) Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med 93:60

    Google Scholar 

  9. Daniels TE, Talal N (1987) Diagnosis and differential diagnosis in Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS (eds) Sjögren's syndrome. Clinical and immunological aspects, 1st edn. Springer, Berlin Heidelberg New York, p 193

    Google Scholar 

  10. Eriksson P, Denneberg T, Granerus G, Lindström F (1995) Glomerular filtration rate in primary Sjögren's syndrome with renal disease. Scand J Urol Nephrol (in press)

  11. Eriksson P, Denneberg T, Larsson L, Lindström F (1995) Biochemical markers of renal disease in primary Sjögren's syndrome. Scand J Urol Nephrol (in press)

  12. Harrington T, Bunch T, van der Berg C (1983) Renal tubular acidosis. A new look at treatment of musculoskeletal and renal disease. Mayo Clin Proc 58:354

    Google Scholar 

  13. Hodgkinson A (1962) Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci 23:203

    Google Scholar 

  14. Johansson G (1979) Magnesium metabolism. Studies in health, primary hyperparathyroidism and renal stone disease. Scand J Urol Nephrol Suppl 51:1

    Google Scholar 

  15. Larsson L, Tiselius HG (1987) Hyperoxaluria, Miner Electrolyte Metab 13:242

    Google Scholar 

  16. Larsson L, Libert B, Asperud M (1982) Determination of urinary oxalate by reversed-phase ion-pair “high-performance” liquid chromatography. Clin Chem 28:2272

    Google Scholar 

  17. Larsson L, Finnström O, Nilsson B, Öhman S (1983) Evaluation of Radiometer ICA1 as a routine instrument for serum ionized calcium and its application for whole blood capillary samples from newborn infants. Scand J Clin Lab Invest 43 [Suppl 165]:21

    Google Scholar 

  18. Larsson L, Sörbo B, Tiselius HG, Öhman S (1984) A method for quantitative wet chemical analysis of urinary calculi. Clin Chim Acta 140:9

    Google Scholar 

  19. Lawrence R (1974) Assay of serum inorganic phosphate without deproteinisation: automated and manual micromethods. Ann Clin Biochem 11:234

    Google Scholar 

  20. Moutsopoulos HM, Cledes J, Skopouli FN, Elisaf M, Youinou P (1991) Nephrocalcinosis in Sjögren's syndrome: a late sequela of renal tubular acidosis. J Intern Med 230:187

    Google Scholar 

  21. Nicar MJ, Skurla C, Sakhaee K, Pak CYC (1983) Low urinary citrate excretion in nephrolithiasis. Urology 21:8

    Google Scholar 

  22. Nordin BEC, Peacock M, Wilkinson R (1972) Hypercalciuria and renal stone disease. Clin Endocrinol 1:169

    Google Scholar 

  23. Norman ME, Peldman NI, Cohn RM, Roth KS, McCurdy DK (1978) Urinary citrate excretion in the diagnosis of distal renal tubular acidosis. J Pediatr 92:394

    Google Scholar 

  24. Pokorny G, Sonkodi S, Iványi B, Mohácsi G, Csáti S, Iványi T, Ormos J (1989) Renal involvement in patients with primary Sjögren's syndrome. Scand J Rheumatol 18:231

    Google Scholar 

  25. Preminger GM, Sakhaee K, Skurla C, Pak CYC (1985) Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20

    Google Scholar 

  26. Robertson WG, Peacock M, Nordin BEC (1968) Activity products in stone-forming and non-stone-forming urine. Clin Sci 34:579

    Google Scholar 

  27. Shioji R, Furuyama T, Onodera S, Saito H, Ito H, Sasaki Y (1970) Sjögren's syndrome and renal tubular acidosis. Am J Med 48:456

    Google Scholar 

  28. Talal N, Zisman E, Shur PH (1968) Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum 11:774

    Google Scholar 

  29. Tiselius HG (1984) A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur Urol 10:191

    Google Scholar 

  30. Tiselius HG (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255

    Google Scholar 

  31. Tiselius HG, Larsson L (1981) Biochemical evaluation of patients with urolithiasis. Eur Urol 7:31

    Google Scholar 

  32. Tiselius HG, Almgård LE, Larsson L, Sörbo B (1978) A biochemical basis for grouping of patients with urolithiasis. Eur Urol 4:241

    Google Scholar 

  33. Tompkins D, Toffaletti J (1982) Enzymatic determination of citrate in serum and urine, with use of the Worthington “Ultrafree” device. Clin Chem 28:192

    Google Scholar 

  34. Trudeau DL, Freier EF (1967) Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 13:101

    Google Scholar 

  35. Tu WH, Shearn MA, Lee JC, Hopper J (1968) Interstitial nephritis in Sjögren's syndrome. Ann Intern Med 69:1163

    Google Scholar 

  36. Vitali C, Tavoni A, Sciuto M, Maccheroni M, Moriconi L, Bombardieri S (1991) Renal involvement in primary Sjögren's syndrome: a retrospective-prospective study. Scand J Rheumatol 20:132

    Google Scholar 

  37. Wrong OM, Feest TG (1980) The natural history of distal renal tubular acidosis. Contrib Nephrol 21:137

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Lanssjukhuset Ryhov, S-551 85, Jönköping, Sweden

    P. Eriksson

  2. Department of Urology, University Hospital, Faculty of Health Sciences, Linköping, Sweden

    T. Denneberg & H. -G. Tiselius

Authors
  1. P. Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Denneberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. -G. Tiselius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eriksson, P., Denneberg, T. & Tiselius, H.G. Risk factors of calcium stone formation in patients with primary Sjögren's syndrome. Urol. Res. 24, 39–43 (1996). https://doi.org/10.1007/BF00296732

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296732

Key words

Search

Navigation